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Abstract
Background: Severe mental illness (SMI) has been associated with more medical co-morbidity and
less cardiovascular procedure use for older patients with myocardial infarction. However, it is
unknown whether SMI is associated with increased long term mortality risk among patients
presenting with acute coronary syndromes (ACS). We tested the hypothesis that SMI is associated
with higher one-year mortality following ACS hospitalization.
Methods: All ACS patients (n = 14,194) presenting to Veterans Health Administration (VHA)
hospitals between October 2003 and September 2005 were included. Survival analysis evaluated
the association between SMI and one-year all-cause mortality, adjusting for demographics, co-
morbidities, in-hospital treatment, and discharge medications.
Results: Overall, 18.4 % of ACS patients had SMI. Patients with SMI were more likely female,
younger, Caucasian race, have a history of alcohol abuse, liver disease, dementia, hypertension and
more likely to be a current smoker; however, prior cardiac history was similar between the 2
groups. There were no significant differences in cardiac procedure use, including coronary
angiogram (38.7% vs. 40.3%, p = 0.14) or coronary revascularization (31.0% vs. 32.3%, p = 0.19),
and discharge medications between those with and without SMI. One-year mortality was lower for
patients with SMI (15.8% vs. 19.1%, p < 0.001). However, in multivariable analysis, there were no
significant differences in mortality (HR 0.91; 95% CI 0.81–1.02) between patients with and without
SMI.
Conclusion: Among ACS patients in the VHA, SMI is prevalent, affecting almost 1 in 5 patients.
However, patients with SMI were as likely to undergo coronary revascularization and be prescribed
evidence-based medications at hospital discharge, and were not at elevated risk of adverse 1-year
outcomes compared to patients without SMI.
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Background
Acute Coronary Syndrome (ACS), including unstable
angina and acute myocardial infarction (AMI), accounts
for over 800,000 hospitalizations yearly [1]. Prior studies
have shown that disparities exist for AMI care according to
socio-economic status, age, gender, and race. Further-
more, these disparities in AMI care have been associated
with differential patient outcomes. For example, women
with AMI are less likely to receive acute reperfusion ther-
apy and have higher in-hospital mortality rates compared
to men [2-7].
More recently, concerns have been raised regarding poten-
tial disparities in AMI care for patients with severe mental
illness (SMI), including schizophrenia, mood disorders,
anxiety disorders and personality disorders. Prior studies
have found that patients with SMI were less likely to
receive coronary revascularization and have higher risk of
death following AMI [8-10]. The cited reasons for this ine-
quality include increased medical comorbidity, reduced
access to medical technology, social isolation, low
income, interference with informed consent because of
the cognitive symptoms and provider hesitation to aggres-
sively treat SMI patients [8-10]. However, it is unknown
whether this disparity exists in a fully integrated system,
such as the VHA (Veterans Health Administration), where
there is more equal access to medical technology.
Accordingly, the objective of this study was to evaluate the
association between SMI and outcomes (1-year all-cause
mortality and all-cause mortality or re-hospitalization for
AMI) in a national Veterans Health Administration (VHA)
cohort of ACS patients hospitalized from 2003 to 2005.
We hypothesized that ACS patients with severe mental ill-
ness would undergo less coronary revascularization dur-
ing the index hospitalization and have higher 1-year all-
cause mortality and AMI re-hospitalization. The results of
this study may have important implications regarding dis-
parities in AMI care and outcomes.
Methods
Information for this study was collected as part of the
VHA External Peer Review Program (EPRP) for quality
monitoring and improvement for a variety of medical
conditions and procedures, including AMI and unstable
angina (UA). Patients with International Classification of
Diseases 9th Revision diagnosis codes 410.xx and 411.xx
were identified from the VA Patient Treatment File. Work-
ing with the EPRP abstraction contractor, West Virginia
Medical Institute, the VHA Office of Quality and Perform-
ance generated a list of patients that was transmitted to
VHA facilities where both paper and electronic medical
records were manually abstracted by trained abstractors
using standard reporting forms. Abstracted data were then
entered into a database maintained by the contractor.
Additional details of the study methods have been pub-
lished [11].
Subjects
All patients admitted with AMI or UA as documented by
standard electrocardiographic criteria, elevated troponin
levels, and/or other clinical evidence and discharged from
VHA medical centers between 10/1/2003 and 9/30/2005
were included. Patients who were transferred from or to a
non-VHA hospital, patients who left against medical
advice and patients who died during the index hospitali-
zation were excluded. The analytical cohort for the current
study was 14,194 patients.
The primary independent predictor variable of interest
was the presence of severe mental illness (SMI). Consist-
ent with other literature, patients were categorized as hav-
ing SMI if they had any one or more of the following ICD-
9 diagnosis codes: Schizophrenia (295.30, 295.10,
295.20, 295.90); Mood disorders (296.3X, 296.40,
296.4X, 296.6X, 296.5X, 296.7, 296.89) However, mood
disorders specified as mild or either partial or full remis-
sion were not included; Anxiety disorders (300.01,
300.21,300.22, 300.23, 300.3, 309.81, 300.02); Personal-
ity disorders (301.0, 301.20, 301.22, 301.7, 301.83,
301.50, 301.81, 301.82, 301.6, 301.4, 301.9) [10].
Outcome variables
The primary outcome for this study was 1-year all-cause
mortality. The secondary outcome was the combined end-
point of all-cause mortality or re-hospitalization for AMI,
within 1-year following the index ACS admission. All-
cause mortality was defined using the Vital Statistics data-
base, which combines four sources of VA mortality data;
VA Beneficiary Identification and Record Locator, in-
patient file, Medicare and Social Security Administration.
When compared against the National Death Index, the
sensitivity was over 98% [12]. Re-hospitalization for AMI
was defined using a primary discharge ICD-9 diagnosis
code of 410.XX.
Statistical analyses
Baseline patient characteristics, co-morbidities, presenta-
tion factors, hospital treatment and discharge medica-
tions among eligible patients were compared between
patients with and without SMI using the Chi-square test
for categorical variables and t-test for continuous meas-
ures. The unadjusted survival was compared between
patients with and without SMI using the Kaplan-Meier
method. Survival was measured beginning at hospital dis-
charge and censored at the time of death or re-hospitaliza-
tion for AMI. Differences in event rates were evaluated
with the log-rank test. Next, a series of multivariable Cox
regression models were constructed to assess the associa-
tion between SMI and mortality with incremental adjust-BMC Health Services Research 2007, 7:146 http://www.biomedcentral.com/1472-6963/7/146
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ment for demographic, cardiac, and non-cardiac
variables, presentation variables, in-hospital procedures
and discharge medications as listed in the Table 1. The
same multivariable models were constructed to assess the
association between SMI and the combined outcome of
all-cause mortality or re-hospitalization for AMI. Because
the association between SMI and the outcomes showed
no differences in significance or magnitude of effect across
the incremental models, only the results of the final
model are reported.
In secondary analysis, we assessed the association
between SMI and outcomes among the following patient
subgroups: unstable angina or acute myocardial infarc-
tion, age ≥ 65 or < 65, prior known coronary artery dis-
ease, and the subgoups of SMI diagnoses including,
schizophrenia, mood or anxiety disorder and personality
disorder.
All analyses were done using Stata version 9.0 (StataCorp,
College Station, TX). This study was approved by the Uni-
versity of Washington Institutional Review Board and
waiver of informed consent was granted.
Results
Characteristics of the study population are outlined in
Table 1. Overall, 18.4% (n = 2,623) of the study popula-
tion had a diagnosis of SMI. Of the patients with SMI,
65.5% (n = 1718) had a diagnosis of anxiety disorder,
47.1% (n = 1235) had a diagnosis of mood disorder,
15.5% (n = 406) had a diagnosis of schizophrenia, and
11.7% (n = 307) had a diagnosis of personality disorder
(not mutually exclusive categories). Patients with SMI
were younger, more often Caucasian, and more often
female. They were more likely to have a diagnosis of alco-
hol abuse, liver disease, and dementia, and to be current
smokers. Prior cardiac history was similar between the 2
groups, except that patients with SMI were less likely to
have had prior CABG surgery.
Among eligible patients, there were no significant differ-
ences in the rates of receipt of diagnostic coronary angi-
ogram and coronary revascularization between patients
with and without SMI (Figure 1). At hospital discharge,
there were similar prescription rates for aspirin, ACE-
inhibitor/ARB, and β-blocker medications between the 2
patient groups (Figure 1). In unadjusted analysis, the free-
dom from event rate was significantly higher among SMI
Table 1: Characteristics of the study population
Variables No SMI N = 11571(81.6%) SMI N = 2623 (18.4%) p-value
Demographic
Mean age (SD), yrs 69.6 (11.5) 64.0 (11.7) < 0.001
Male 11357 (98.1%) 2548 (97.1%) 0.001
Caucasian race 5943 (51.4%) 1553 (59.2%) < 0.001
BMI (SD) 27.9 (5.9) 28.9(6.4) < 0.001
Cardiac
Prior AMI 2757 (23.8%) 628 (23.9%) 0.900
Prior CHF 3259 (28.2%) 7317 (27.9%) 0.760
Prior CABG 2509 (21.7%) 502 (19.1%) 0.004
Prior PCI(6 m) 487 (4.2%) 124 (4.7%) 0.237
Non-Cardiac
Alcohol abuse 1037 (9.0%) 725 (27.6%) < 0.001
Cancer 1098 (9.5%) 174 (6.6%) < 0.001
COPD 2149 (18.6%) 532 (20.3%) 0.043
Dementia 1016 (8.8%) 967 (36.9.0%) < 0.001
Lipid disorder 7327 (63.3%) 1655 (63.1%) 0.828
Liver disease 469 (4.1%) 227 (8.6%) < 0.001
Cerebral Vascular Disease 1072 (9.3%) 242 (9.2%) 0.951
Musculoskeletal 761 (6.6%) 188 (7.2%) 0.274
Renal disease 2547 (22.0%) 508 (19.4%) 0.003
Diabetes 2396 (20.7%) 556 (21.2%) 0.577
Current smokers 3301 (28.5%) 1161 (44.3%) < 0.001
Hypertension 10155 (87.8%) 2355 (89.8%) 0.004
Peripheral Vascular Disease 3542 (30.6%) 711 (27.1%) < 0.001
Presentation
Heart rate 85.6 (23.0) 84.9 (22.0) 0.130
Systolic blood pressure 140 (30.0) 138 (29) 0.001
Diastolic blood pressure 76 (18.0) 77 (19) 0.012
BMI, body mass index; AMI, myocardial infarction; CHF, chronic heart failure; COPD, Chronic obstructive pulmonary disease; CABG, coronary 
artery bypass graft; PCI, percutaneous coronary intervention; COPD, Chronic obstructive pulmonary disease; Cath, Cardiac Catheterization;BMC Health Services Research 2007, 7:146 http://www.biomedcentral.com/1472-6963/7/146
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patients compared to those without SMI for 1-year all-
cause mortality (84.2% vs 80.9%, p < 0.01) and the com-
bined endpoint of all-cause mortality and re-hospitaliza-
tion (78.0% vs 75.6%, p = 0.01) for AMI (Figures 2 and 3).
However, after adjustment for demographic, cardiac and
non-cardiac co-morbidities, presentation factors, in-hos-
pital procedures and discharge medications, there was no
significant association between SMI and all-cause mortal-
ity (HR 0.91; 95% CI 0.81–1.02) or the combined end-
point of all-cause mortality and re-hospitalization for
AMI, (HR 0.99; 95% 0.90–1.10). The findings were con-
sistent when analyzed by subgroups of SMI ; schizophre-
nia (0.83; 95% CI 0.60–1.15), mood/anxiety disorder
(0.91; 95% CI 0.79–1.06), and personality disorder (1.0;
95% CI 0.68–1.5). Additionally, the association between
SMI and outcomes remained consistent when analyzed by
different patient subgroups, including unstable angina or
myocardial infarction, age ≥ 65 or < 65, and prior known
coronary artery disease.
Discussion
The goal of this study was to assess the association
between SMI and 1-year all-cause mortality and AMI re-
hospitalization among a national cohort of veterans with
ACS. Overall, 18.4% of the study population had a diag-
nosis of SMI. There were no significant differences in the
rates of coronary angiography, PCI or CABG during the
index hospitalization or prescription rates of evidence-
based discharge medications between patients with and
without SMI. Finally, there were no significant differences
in risk-adjusted 1-year all-cause mortality or AMI re-hos-
pitalization between ACS patients with and without SMI.
The existing literature on the association between SMI and
outcomes following acute myocardial infarction has been
mixed. In prior studies, the prevalence of SMI among
patients presenting with AMI ranged from 4.7% to 40%
depending on the population studied and the definitions
used for SMI. While other studies have had a broader def-
inition of SMI and included diagnoses such as other psy-
choses, alcohol/substance abuse disorders, and/or
adjustment reaction as part of their definition, we had a
more restricted definition and only included patients with
schizophrenia, mood disorders, anxiety disorders and
personality disorders [8-10,13,14]. In addition, previous
studies have shown that patients with severe mental ill-
Freedom from 1-year mortality Figure 2
Freedom from 1-year mortality.
Comparison of receipt of care SMI and non-SMI patients Figure 1
Comparison of receipt of care SMI and non-SMI 
patients. Cath = Cardiac Catheterization ; PCI = percutane-
ous coronary intervention; CABG = coronary artery bypass 
graft; ACEI/ARB = angiotensin-converting enzyme inhibitors/
Angiotensin II Receptor Blockers;
Freedom from 1-year mortality/re-hospitalization Figure 3
Freedom from 1-year mortality/re-hospitalization.BMC Health Services Research 2007, 7:146 http://www.biomedcentral.com/1472-6963/7/146
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ness were less likely to undergo diagnostic coronary angi-
ography, and revascularization procedures and had a
trend towards higher 1 year mortality following AMI hos-
pitalization [8-10,14]. In contrast, we assessed a contem-
porary cohort of ACS patients with SMI in a large
integrated health care system, used chart abstracted data
for risk-adjustment, and performed sensitivity analyses
among strata of SMI and patient subgroups. We found
that there were no significant differences in the rates of
coronary angiography and coronary revascularization
between eligible patients with and without SMI and 1-
year all-cause mortality and AMI re-hospitalization. These
findings suggest that the presence of SMI among patients
presenting with ACS does not negatively impact in-hospi-
tal care or long-term outcomes in the VHA.
There are several potential explanations for our findings
of no difference in outcomes between patients with or
without SMI presenting with ACS in the VHA. First, access
to care may be less of an issue for SMI patients in the VHA
compared to other healthcare settings. Other studies of
patients in the VHA have shown no disparities of care and
outcomes by race and gender [15,16]. Second, a prior
study found that VA physicians were more likely to initi-
ate mental health referral for patients with depression
compared to non-VA physicians [17]. One potential
explanation is that mental health disorders are common
among veterans and because it is a common condition,
there may be less of a physician bias in the VHA compared
to non-VHA settings. Finally, prior studies have shown
that a collaborative care model between primary care and
mental health providers for VHA patients with depression
is associated with more rapid improvement in symptoms
as well as mental health status [18,19]. Additional studies
are needed to determine if such a care model for patients
with concomitant cardiovascular and severe mental ill-
ness will lead to improved patient outcomes.
There are several limitations of this study which should be
acknowledged. The results of this study may not be gener-
alizable to all patients with SMI who are hospitalized for
ACS because our study cohort comprised of veterans who
were predominantly male, older, and had significant
comorbidities. Additionally, we were unable to adjust for
the veterans socioeconomic status. However, VHA eligi-
bility is determined by disability related to military service
or by economic disadvantage [20]. This study included a
national cohort of all patients with ACS in the VHA from
2003 through 2005 and therefore represents practice pat-
terns for patients with SMI and ACS in a large integrated
healthcare system. Second, we defined SMI using ICD-9
codes and, therefore, could not assess the severity of a
patients' mental illness and future studies should assess
whether patient outcomes following ACS hospitalization
vary according to the severity of the underlying mental
disorder. Third, we did not observe a difference in 1-year
outcomes following ACS hospitalization between patients
with and without SMI, raising the possibility of Type II
error. However, we had 99% power to detect an absolute
mortality difference of 3.5% between the 2 comparison
groups.
Conclusion
In summary, we found that among ACS patients in the
VHA, SMI is prevalent affecting almost 1 in 5 ACS
patients. However, patients with SMI were just as likely to
undergo coronary revascularization and to be prescribed
evidence-based medications at hospital discharge com-
pared to patients without SMI. One-year mortality and re-
hospitalization for MI were similar between the two
groups. Thus, there is no evidence for disparity in care and
outcomes based on the presence of SMI among ACS
patients in the VHA.
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